AI-based antibody discovery platform identifies novel, diverse, and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strains.
Loomis CM, Lahlali T, Van Citters D, Sprague M, Neveu G, Somody L, Siska CC, Deming D, Asakawa AJ, Amimeur T, Shaver JM, Carbonelle C, Ketchem RR, Alam A, Clark RH.
Loomis CM, et al. Among authors: somody l.
Antib Ther. 2024 Sep 26;7(4):307-323. doi: 10.1093/abt/tbae025. eCollection 2024 Oct.
Antib Ther. 2024.
PMID: 39381135
Free PMC article.